Status:
COMPLETED
Ventilatory Weaning Guided by a New Index
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Respiration, Artificial
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
Mechanical ventilation (MV) is an essential therapy for patients with acute respiratory failure. The ventilatory weaning process should be started when the precipitating causes of the use of the venti...
Detailed Description
Mechanical ventilation (MV) is an essential therapy for patients with acute respiratory failure. The ventilatory weaning process should be started when the precipitating causes of the use of the venti...
Eligibility Criteria
Inclusion
- Inclusion and exclusion criteria
- Our study included patients over 18 years old, under mechanical ventilation, who remained for more than 24 hours of invasive ventilatory assistance and who were able to start the process of weaning. Exclusion criteria comprised tracheostomy, chronic neurological disorders, low level of alertness, and chronic immune suppression states, including positive serology for HIV.
Exclusion
Key Trial Info
Start Date :
October 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2021
Estimated Enrollment :
144 Patients enrolled
Trial Details
Trial ID
NCT04512677
Start Date
October 29 2019
End Date
January 10 2021
Last Update
August 16 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade Federal Fluminense
Niterói, Rio de Janeiro, Brazil, 24033-900
2
Hospital e Clínica São Gonçalo
São Gonçalo, Rio de Janeiro, Brazil